Loading stock…

Geron Corporation (GERN) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Geron Corporation

GERNMarket cap $0.77BPrice $1.2

Country🇺🇸United States

SectorHealthcare

IndustryBiotechnology

Develops treatments for blood cancers and bone marrow diseases, headlined by imetelstat, its telomerase inhibitor now FDA-approved for transfusion-dependent anemia. Decades of research bet on one bold idea: stopping cancer cells from achieving biological immortality.

In Bastion Portfolios?

52W Return+0%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+576%10

Revenue Forecast

Rev CAGR (1y)+28%9

Rev CAGR (3y)+36%10

Rev CAGR (5y)+39%10

Earnings Forecast

EPS Growth Y+1Loss1

EPS Growth Y+20%5

EPS Growth Y+3+246%10

Quality

Margins

EBIT Margin-17%1

Net Income Margin-33%1

Free Cash Flow Margin-56%1

Debt

Net Debt/EBITDAna–

Efficiency

ROE-28%1

ROA-13%1

Earnings Stabilityna–

GEAR+WEAK15

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)521

P/E Ratio (Forward 3y)79

P/BV3.54

EV Multiples

EV/EBITDA Fwdna–

EV/EBIT Fwdna–

Yield

Free Cash Flow Yield-14.9%1

Dividend Yieldna–

Momentum

Short term

1 month return-21%1

3 month return-23%1

YTD return-9%3

Mid term

Price vs 52wHigh60%2

1 year return-13%3

Long term

3 year return-34%1

5 year return-9%3

Risk Shield

Price Risk

Beta1.52

Volatility63%2

Free Cash Flow

Free Cash Flow Margin-56%1

Free Cash Flow Yield-14.9%1

Quality

ROCE-8%1

Earnings Stabilityna–

Net Debt/EBITDAna–

02Growth

Is it actually growing, and how fast?

GERNGeron

Revenue FY25$184M

GROWTH RATING↗

VERY STRONG95 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+576%10

Revenue, next 1Y+28%9

Revenue, next 3Y, CAGR+36%10

Revenue, next 5Y, CAGR+39%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26ELoss1

EPS growth, FY27E0%5

EPS growth, FY28E+246%10

GROWTH ASSESSMENT

STRENGTHS

It out-grows 95% of companies worldwide.

Revenue grew 576%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 36%/yr over the next 3 years, ahead of most of the market.10/10

The runway holds up: revenue is set to grow 39%/yr over five years.10/10

WATCH

Revenue grew 576%/yr over the last 3 years; forecasts see it cooling to 36%/yr.

WEAKNESSES

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Top-Line Rocket

A top-tier grower that is slowing. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY WEAK3 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-21%1

3-month return-23%1

YTD return-9%3

MID & LONG-TERM▾SCORE

% of 52-week high60%2

1-year return-13%3

3-year return-34%1

5-year return-9%3

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-34% over three years and -9.1% over five), behind 80% of the market.

It's down 13% over the past year, now 40% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-21%), over three months (-23%) and so far this year (-9%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Geron Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

GERNGeron

Revenue FY25$184M

GROWTH RATING↗

VERY STRONG95 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+576%10

Revenue, next 1Y+28%9

Revenue, next 3Y, CAGR+36%10

Revenue, next 5Y, CAGR+39%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26ELoss1

EPS growth, FY27E0%5

EPS growth, FY28E+246%10

GROWTH ASSESSMENT

STRENGTHS

It out-grows 95% of companies worldwide.

Revenue grew 576%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 36%/yr over the next 3 years, ahead of most of the market.10/10

The runway holds up: revenue is set to grow 39%/yr over five years.10/10

WATCH

Revenue grew 576%/yr over the last 3 years; forecasts see it cooling to 36%/yr.

WEAKNESSES

The company is loss-making, so its revenue growth is not backed by profit yet.

BOTTOM LINE

Top-Line Rocket

A top-tier grower that is slowing. The one thing to watch: the company is not profitable yet.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

VERY WEAK3 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-21%1

3-month return-23%1

YTD return-9%3

MID & LONG-TERM▾SCORE

% of 52-week high60%2

1-year return-13%3

3-year return-34%1

5-year return-9%3

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-34% over three years and -9.1% over five), behind 80% of the market.

It's down 13% over the past year, now 40% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-21%), over three months (-23%) and so far this year (-9%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on Geron Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community